“I am thrilled to join such an innovative company at the forefront of gene editing,” said Briggs Morrison, M.D. “I look forward to collaborating with the Board and the management team to drive CRISPR ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

'Mad Money' host Jim Cramer weighs in on stock including: Lincoln Electric, Caesars Entertainment, CRISPR, and Seagate. This ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Genetic engineering, the science of altering DNA to improve or change the characteristics of living things, is making huge ...

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...

Thanks to AI developments, we are witnessing a dramatic increase in the pace and scalability of genomic techniques, which ...